Search

Search Results
Results 4661 - 4670 of 4741 for multiple sclerosis
  • Gross sales of Acorda Therapeutics' ZANAFLEX CAPSULES and tablets increase 9.1% to $58.3M in 2009
    News - 23 Feb 2010
    Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2009.
  • Cimzia
    Drug - 24 Nov 2025
    Consumer Medicine Information (CMI) about Cimzia intended for persons living in Australia.
  • Codalgin Forte
    Drug - 6 Nov 2025
    Consumer Medicine Information (CMI) about Codalgin Forte intended for persons living in Australia.
  • Diabex XR 500 and 1000
    Drug - 28 Oct 2025
    Consumer Medicine Information (CMI) about Diabex XR 500 and 1000 intended for persons living in Australia.
  • Diabex
    Drug - 28 Oct 2025
    Consumer Medicine Information (CMI) about Diabex intended for persons living in Australia.
  • Metformin XR Mylan
    Drug - 27 Oct 2025
    Consumer Medicine Information (CMI) about Metformin XR Mylan intended for persons living in Australia.
  • Hexaxim
    Drug - 16 Oct 2025
    Consumer Medicine Information (CMI) about Hexaxim intended for persons living in Australia.
  • Prodeinextra
    Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Prodeinextra intended for persons living in Australia.
  • Prodeine
    Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Prodeine intended for persons living in Australia.
  • Prodeine Forte
    Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Prodeine Forte intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback